logo
From Strategy To Implementation: Leveraging Unstructured Health Data

From Strategy To Implementation: Leveraging Unstructured Health Data

Forbes5 days ago
Dr. Tim O'Connell is a practicing radiologist and the founder and CEO of emtelligent, a developer of clinical-grade AI software.
The healthcare industry is experiencing a data transformation that began with the 2009 HITECH Act and has since gained momentum through initiatives like the 21st Century Cures Act and CMS's Promoting Interoperability Program. These policies have shifted the focus from electronic health record (EHR) adoption to value-based care, emphasizing interoperability, data sharing and patient access.
By 2020, U.S. healthcare data had reached 2,314 exabytes—15 times more than in 2013—thanks to connected devices and remote monitoring. This surge has turned data into a critical asset, with unstructured clinical data offering particularly untapped value.
Until recently, this data could only be accessed via labor-intensive manual review. Organizations seeking to unlock this critical 'last mile' of clinical data and put it to work across multiple use cases face numerous considerations and pitfalls along the way.
In my experience working with clients across healthcare industry sectors, I have identified the emergence of a maturity curve for organizations as they move toward the utilization of unstructured clinical data. This curve includes the following stages:
1. Opportunity: Realizing there is valuable data hiding within unstructured clinical records that can be extracted and analyzed to improve care, increase efficiency and inform research.
2. Competency: Understanding that advanced tools like artificial intelligence (AI) and natural language processing (NLP) hold the key to unlocking unstructured data at scale, readying it for insights and business processes.
3. Viability: Identifying and defining the value dimensions and key performance indicators (KPIs) that unstructured data can impact, such as reducing time to diagnosis, identifying gaps in care or streamlining reimbursement, that are aligned with business and clinical objectives.
4. Feasibility: Building and operationalizing a scalable data pipeline that can rapidly and efficiently process high volumes of unstructured data across diverse clinical sources and formats.
5. Extensibility: Scaling proven use cases across the enterprise and embedding unstructured data analysis into core workflows, strategic initiatives and population health efforts.
This article focuses on the first two stages: identifying the opportunity and understanding enabling technologies.
Buried Treasure
An estimated 80% of clinical data is unstructured. Even documents using structured formats like C-CDA often include vast narrative content—especially for patients with complex conditions. Much of this critical information remains invisible to conventional analytics.
Keyword search tools, still common in healthcare, lack contextual understanding. They often miss key insights or provide irrelevant results because they can't interpret negation, chronology or relationships between concepts. Without sophisticated tools, unstructured data is underused—resulting in missed clinical context, risk miscalculations and missed research opportunities.
Enabling Intelligent Data Access At Scale
Advanced technologies like AI and NLP are rapidly transforming how healthcare organizations engage with unstructured data—replacing manual review processes with intelligent automation that is faster, more scalable and more accurate.
And this isn't just an opinion; peer-reviewed studies back it up. A 2024 review of how wider healthcare is implementing NLP and AI found that 81% of systems were using NLP to extract clinical data from EHRs. That's a big deal because it means faster access to important information across workflows. And in a study of data from more than 4,000 stroke patients admitted to Massachusetts General Hospital, NLP accurately pulled stroke severity scores from doctors' notes—matching expert reviews more than 92% of the time and removing the need for manual chart review. It's a powerful example of how this technology can drive real impact at scale.
Unlike traditional search tools that rely on static keyword matching, these advanced systems understand the context, semantics and structure of language. They recognize synonyms, interpret negation (e.g., 'no history of diabetes'), differentiate between historical and current conditions and extract relationships between clinical concepts (e.g., linking a symptom to a diagnosis or a medication to a specific condition). This deeper understanding enables them to surface more relevant and actionable insights while minimizing false positives and irrelevant matches.
These technologies also eliminate the need for time-consuming manual chart review, freeing up clinicians, analysts and administrative teams to focus on higher-value tasks. Rather than reading through hundreds of pages of clinical notes, users can instantly extract structured summaries, quality measures, risk indicators and cohort-specific criteria.
By transforming narrative data into structured, searchable insights, AI and NLP enable a wide range of use cases:
• Supporting real-time clinical decision-making
• Powering predictive analytics for earlier interventions
• Identifying gaps in care for population health management
• Accelerating patient recruitment for clinical trials
• Enhancing claims processing and risk adjustment accuracy
• Surveillance for public health
Best Practices For Harnessing AI In Healthcare
Implementing AI in healthcare isn't just about choosing the right tools—it's about making them work in the real world. In my experience, the biggest challenges show up after the technology is in place. Success depends on how well teams understand the problem they're trying to solve and how much trust exists in the system.
A few best practices can help:
• Start with one clear use case. Whether it's chart abstraction, quality reporting or cohort identification, narrowing the focus makes it easier to prove value and build momentum.
• Prioritize transparency. If users can't trace an insight back to the source, they're not going to trust it. Make sure outputs are verifiable and easy to audit.
• Support the humans doing the work. AI should reduce manual effort, not override clinical judgment. Adoption improves when teams see that it will make their jobs easier.
• Be clear about who is accountable. Even with AI at the helm, someone still needs to own the final decision. Build governance around who reviews outputs and how errors are caught and corrected.
• Broadcast success and enlist champions. Identify one or two business or clinical advocates to embed AI into their workflows and showcase throughput gains, cost savings and how AI can free up clinicians for higher-value work and patient interaction.
These practices don't merely help with implementation. They lay the groundwork for everything that comes after.
Finally, with those foundations in place, teams can move from theory to real-world results.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Third Fatal Liver Failure Hits Sarepta Gene Trial
Third Fatal Liver Failure Hits Sarepta Gene Trial

Yahoo

time27 minutes ago

  • Yahoo

Third Fatal Liver Failure Hits Sarepta Gene Trial

Sarepta (NASDAQ:SRPT) has now seen a third fatal incident in its gene therapy trials due to acute liver failure. That happened last month in a limb girdle muscular dystrophy study and follows two teenage deaths in advanced Duchenne muscular dystrophy patients. The trial was halted and Elevidys distribution paused for non walking patients. Warning! GuruFocus has detected 3 Warning Signs with SRPT. The company reported the latest death promptly to regulators and agreed to alert doctors and patients about liver failure risks as the FDA requested. Talks are underway on how to protect non walking patients going forward. To steady its finances, Sarepta will cut more than a third of its workforce and pause several drug programs. This move is expected to save around four hundred million dollars a year. Investors will watch closely for signs that these steps can rebuild confidence. This article first appeared on GuruFocus.

White House Wants Bias-Free AI for Government Work
White House Wants Bias-Free AI for Government Work

Yahoo

time27 minutes ago

  • Yahoo

White House Wants Bias-Free AI for Government Work

The White House is cooking up an order to make sure AI tools that work with the government stay politically neutral. Officials worry models trained on internet data can drift into liberal or conservative slants, so this would set a clear standard. Warning! GuruFocus has detected 3 Warning Sign with UAL. At the center of the plan is AI czar David Sacks, who has pointed to embarrassing moments like Google's Gemini painting a black George Washington or diverse Nazis. OpenAI, Anthropic, Google (NASDAQ:GOOG) and Elon Musk's xAI fear it could pick industry winners and spark free speech fights. This order lands just as the Pentagon is handing out nearly two hundred million dollars in AI contracts. Tying neutrality to federal deals could shift who wins big and shape how the industry builds its next generation of tools. It also comes bundled with moves to boost chip exports and speed data center approvals. As Washington juggles bias concerns and tech rivalry with China, investors will be watching every step. This article first appeared on GuruFocus. Sign in to access your portfolio

Bullish Files for IPO in Latest Crypto Push Onto Public Market
Bullish Files for IPO in Latest Crypto Push Onto Public Market

Yahoo

time27 minutes ago

  • Yahoo

Bullish Files for IPO in Latest Crypto Push Onto Public Market

(Bloomberg) -- Bullish, the digital-asset exchange and owner of news and data website CoinDesk, filed for an initial public offering in the latest example of the cryptocurrency industry's aggressive push onto public markets. The Dutch Intersection Is Coming to Save Your Life Mumbai Facelift Is Inspired by 200-Year-Old New York Blueprint Advocates Fear US Agents Are Using 'Wellness Checks' on Children as a Prelude to Arrests LA Homelessness Drops for Second Year How San Jose's Mayor Is Working to Build an AI Capital The offering is being led by JPMorgan Chase & Co., Jefferies Financial Group Inc., Citigroup Inc., Cantor Fitzgerald LP, Deutsche Bank and Societe Generale. The company plans for its shares to trade on the New York Stock Exchange under the symbol BLSH. 'We intend to IPO because we believe that the digital assets industry is beginning its next leg of growth,' Farley wrote in a letter to investors in a filing with the US Securities and Exchange Commission. 'We view transparency and compliance as hallmarks of how we operate Bullish, and believe those values align well with the public capital markets.' The company, which is headed by former New York Stock Exchange executive Tom Farley, had a net loss of $348.6 million in the three months ended March 31, compared with net income of $104.8 million in the same period a year earlier, according to its filing late Friday. The company raised an estimated $400 million in an early stage venture-capital fundraising round in May 2021, with participation from Black Toro Capital and Presight Capital, according to data provider PitchBook. The filing comes after Gemini Space Station, the crypto outfit controlled by billionaire twins Tyler and Cameron Winklevoss, announced in early June it had filed confidentially for an IPO. Earlier this week, Grayscale Investments, the crypto asset manager controlled by Barry Silbert's Digital Currency Group, said it had confidential submitted a draft registration statement with the SEC but did not explicitly say it was planning an IPO. Activity in the sector has been fueled in part by a surge of more than 600% for stablecoin issuer Circle Internet Group since its June IPO, easily this year's best performing US stock-market debut. A Rebel Army Is Building a Rare-Earth Empire on China's Border What the Tough Job Market for New College Grads Says About the Economy Godzilla Conquered Japan. Now Its Owner Plots a Global Takeover How Starbucks' CEO Plans to Tame the Rush-Hour Free-for-All Why Access to Running Water Is a Luxury in Wealthy US Cities ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store